Sarasota Memorial is among a number of hospitals that have been allocated a limited supply of monoclonal antibody therapy for non-hospitalized patients who have been diagnosed with a mild-to-moderate case of COVID-19 and have a high risk for severe disease or hospitalization. SMH has received a limited supply of the Eli Lilly drug (bamlanivimab) and expects to receive shipments of Regeneron’s experimental antibody treatment (a combination of casirivimab and imdevimab), in the coming weeks/months, as supplies are available.
David Verinder, president and CEO of Sarasota Memorial Health Care System, has been named chair of the Safety Net Hospital Alliance of Florida’s board of directors. The alliance advocates for the state’s 14 flagship safety net health care systems, which play a crucial role in caring for Florida’s most vulnerable citizens.
The Sarasota County Public Hospital Board, which governs Sarasota Memorial Health Care System, installed its 2020-2021 slate of officers. Jim Meister, who has represented Seat 1 in the Northern District since 2015, was re-elected chairman.
Watson Health today announced its 50 Top Cardiovascular Hospitals list, naming Sarasota Memorial among the top-performing U.S. hospitals for inpatient cardiovascular services. SMH was the only Suncoast hospital that made the 2021 list.
Sonia Sharma, MS, MD, joins First Physicians Group Endocrinology with expertise in treating adrenal gland disorders, pituitary dysfunction, thyroid disease, osteoporosis and diabetes with the latest monitoring technology.